Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jamie Spangler"'
Autor:
Rihana S. Bokhari, Afshin Beheshti, Sarah E. Blutt, Dawn E. Bowles, David Brenner, Robert Britton, Lawrence Bronk, Xu Cao, Anushree Chatterjee, Delisa E. Clay, Colleen Courtney, Donald T. Fox, M.Waleed Gaber, Sharon Gerecht, Peter Grabham, David Grosshans, Fada Guan, Erin A. Jezuit, David G. Kirsch, Zhandong Liu, Mirjana Maletic-Savatic, Kyle M. Miller, Ruth A. Montague, Prashant Nagpal, Sivan Osenberg, Luke Parkitny, Niles A. Pierce, Christopher Porada, Susan M. Rosenberg, Paul Sargunas, Sadhana Sharma, Jamie Spangler, Daniel Naveed Tavakol, Dilip Thomas, Gordana Vunjak-Novakovic, Chunbo Wang, Luke Whitcomb, Damian W. Young, Dorit Donoviel
Publikováno v:
Life Sciences in Space Research. 35:105-112
Future lunar missions and beyond will require new and innovative approaches to radiation countermeasures. The Translational Research Institute for Space Health (TRISH) is focused on identifying and supporting unique approaches to reduce risks to huma
Autor:
Jyoti Rana, Derek VanDyke, Maite Munoz, Sandeep RP Kumar, Miguel Gonzales, Jamie Spangler, Moanaro Biswas
Publikováno v:
Blood. 140:7374-7375
Autor:
Ruyan Rahnama, Huilin Yang, Monika Kizerwetter, Stamatia Vorri, Natalie Holl, Ilias Christodoulou, Adam Fearnow, Jamie Spangler, Challice Bonifant
Publikováno v:
Transplantation and Cellular Therapy. 29:S185
Autor:
Ruyan Rahnama, Monika Kizerwetter, Huilin Yang, Ilias Christodoulou, Adam Fearnow, Stamatia Vorri, Jamie Spangler, Challice Bonifant
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S257
Autor:
Aliyah Brianne Silver, Jamie Spangler
Publikováno v:
The Journal of Immunology. 208:122.14-122.14
Interleukin-2 (IL-2) is a pleiotropic cytokine that has clinical utility in stimulating anti-cancer immunity. However, the clinical efficacy of IL-2 is limited by its short serum half-life, systemic toxicity, and concurrent activation of immunostimul
Publikováno v:
The Journal of Immunology. 208:122.01-122.01
Acute myeloid leukemia (AML) is a highly prevalent blood and bone marrow cancer characterized by the uncontrolled growth of abnormal myeloblasts. Current treatments for AML often result in systemic toxicities for patients, many of whom will still exp
Autor:
Jamie Spangler
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::78e3e61ca4716d71048b3e7ab0c52ed4
http://www.scopus.com/inward/record.url?eid=2-s2.0-85019155491&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-85019155491&partnerID=MN8TOARS